The country that produced Dolly the cloned sheep, Viagra and the first IVF baby may find its scientific wings a little clipped when it leaves the European Union.
About 1 billion pounds ($1.3 billion) in research funding may drain out of programs that seek to develop new medicines in coming years, according to analysts at Shore Capital Group Ltd. The U.K. gets more out of the EU’s science budget than it contributes, leaving the national government to decide whether to fill the gap.
